Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,428 | 41 | 98.9% |
| Education | $15.27 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $356.11 | 7 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $186.89 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $186.26 | 4 | $0 (2024) |
| ABBVIE INC. | $178.76 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $166.98 | 5 | $0 (2024) |
| UCB, Inc. | $98.35 | 1 | $0 (2023) |
| Incyte Corporation | $71.42 | 2 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $62.78 | 2 | $0 (2024) |
| LEO Pharma Inc. | $42.82 | 2 | $0 (2024) |
| PFIZER INC. | $34.87 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $627.52 | 21 | ABBVIE INC. ($178.76) |
| 2023 | $646.38 | 15 | Janssen Biotech, Inc. ($153.83) |
| 2022 | $169.80 | 6 | Novartis Pharmaceuticals Corporation ($105.52) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $115.85 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Dermatology | ||||||
| 08/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $41.70 | General |
| Category: Dermatology | ||||||
| 04/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $40.08 | General |
| Category: Dermatology | ||||||
| 03/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $122.00 | General |
| Category: Immunology | ||||||
| 01/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: IMMUNOLOGY | ||||||
| 01/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.08 | General |
| Category: Immunology | ||||||
| 12/19/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Immunology | ||||||
| 12/07/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $98.35 | General |
| 11/16/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $34.75 | General |
| Category: Immunology | ||||||
| 11/09/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,810 | 8,066 | $926,558 | $235,134 |
| 2022 | 21 | 4,001 | 8,295 | $978,698 | $256,215 |
| 2021 | 20 | 3,866 | 8,323 | $972,481 | $263,950 |
| 2020 | 24 | 3,587 | 7,499 | $865,421 | $221,020 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 968 | 1,245 | $233,861 | $57,848 | 24.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 343 | 585 | $205,083 | $54,578 | 26.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 450 | 539 | $115,508 | $33,108 | 28.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 530 | 698 | $111,080 | $23,089 | 20.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 429 | 602 | $69,362 | $18,241 | 26.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 452 | 3,613 | $53,545 | $14,556 | 27.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 211 | 211 | $48,897 | $11,452 | 23.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 123 | 200 | $22,418 | $6,516 | 29.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 76 | 107 | $12,627 | $2,700 | 21.4% |
| 69100 | Biopsy of ear | Office | 2023 | 49 | 53 | $11,343 | $2,543 | 22.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 29 | 36 | $8,481 | $2,236 | 26.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 55 | 55 | $8,645 | $2,163 | 25.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $7,082 | $2,037 | 28.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 16 | $8,424 | $1,623 | 19.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 14 | 14 | $3,767 | $1,123 | 29.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 14 | $5,186 | $1,121 | 21.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 20 | $1,081 | $163.03 | 15.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 47 | $168.26 | $37.72 | 22.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 373 | 630 | $220,859 | $61,282 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 962 | 1,209 | $227,099 | $57,842 | 25.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 479 | 572 | $122,580 | $35,263 | 28.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 558 | 723 | $115,058 | $23,978 | 20.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 442 | 605 | $69,708 | $19,501 | 28.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 486 | 3,669 | $54,375 | $15,080 | 27.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 212 | 212 | $49,129 | $11,645 | 23.7% |
About Tamara Vandyke, PA-C
Tamara Vandyke, PA-C is a Dermatology healthcare provider based in Reno, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427053685.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tamara Vandyke, PA-C has received a total of $1,444 in payments from pharmaceutical and medical device companies, with $627.52 received in 2024. These payments were reported across 42 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,428).
As a Medicare-enrolled provider, Vandyke has provided services to 15,264 Medicare beneficiaries, totaling 32,183 services with total Medicare billing of $976,319. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Reno, NV
- Active Since 06/15/2005
- Last Updated 01/12/2015
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1427053685
Products in Payments
- COSENTYX (Drug) $250.59
- Sotyktu (Drug) $186.26
- SKYRIZI (Biological) $178.76
- TREMFYA (Drug) $166.98
- COSENTYX (Biological) $84.06
- OPZELURA (Drug) $71.42
- Zoryve (Drug) $57.72
- ADBRY (Biological) $42.82
- ILUMYA (Biological) $40.08
- CIBINQO (Drug) $34.87
- TALTZ (Drug) $25.34
- Winlevi (Drug) $22.70
- DUPIXENT (Biological) $18.76
- VTAMA (Drug) $14.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Reno
Laura Ostezan, M.d, M.D
Dermatology — Payments: $27,692
Laura Biehle, Pa-C, PA-C
Dermatology — Payments: $25,736
Dr. William Mortensen, M.d, M.D
Dermatology — Payments: $12,827
Mrs. Diane Smith, Aprn, APRN
Dermatology — Payments: $11,999
Mrs. Cindy Lamerson, Md, MD
Dermatology — Payments: $8,873
Dr. Gretchen Korver, M.d, M.D
Dermatology — Payments: $8,444